Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue.
Martin S. Tallman
Martin S. Tallman, MD is Chief, Leukemia Service at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College in New York, USA. He is a diplomate of the American Board of Internal Medicine with sub-specialty certification in the areas of hematology and medical oncology. He served as Chair of the Leukemia Committee of the Eastern Cooperative Oncology Group for 16 years.
Dr Tallman received his bachelor's degree in Science at the University of Michigan in Ann Arbor, Michigan, USA and his medical degree at The Chicago Medical School in Chicago, Illinois, USA. After completing an internship, residencies, and chief residency at McGraw Medical Center at Northwestern University, Dr Tallman completed his fellowship in hematology/oncology at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington, USA. Dr Tallman is a member of numerous committees of national, regional, and international professional societies involved in the study and treatment of cancer, including the American Society of Hematology, American Society of Clinical Oncology, the Eastern Cooperative Oncology Group and the American Association for Cancer Research. He serves as Co-Chair of the on the Acute Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN). He is a fellow of the American College of Physicians.
Dr Tallman has contributed a large body of work to the literature addressing the diagnosis, biology, and treatment of acute leukemia and other hematologic malignancies. This work includes original research articles in peer-reviewed journals, textbook chapters and reviews, monographs, editorials, and abstracts. He has spoken as an invited lecturer and chair at many national and international symposia, conferences, and meetings, including the American Society of Hematology Meeting, the American Society of Clinical Oncology Meeting, and the CIBMTR Tandem Annual Meeting.
Dr Tallman completed two terms as an Associate Editor of Blood. He is a reviewer for many professional publications, including American Journal of Hematology, Annuals of Internal Medicine, Bone Marrow Transplantation, Cancer Research, Journal of Clinical Oncology, and New England Journal of Medicine. He currently serves as the President-Elect of the American Society of Hematology.